These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 17285783)

  • 1. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Boloña ER; Uraga MV; Haddad RM; Tracz MJ; Sideras K; Kennedy CC; Caples SM; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):20-8. PubMed ID: 17285782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone for peri- and postmenopausal women.
    Somboonporn W; Davis S; Seif MW; Bell R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004509. PubMed ID: 16235365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials.
    Tracz MJ; Sideras K; Boloña ER; Haddad RM; Kennedy CC; Uraga MV; Caples SM; Erwin PJ; Montori VM
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2011-6. PubMed ID: 16720668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.
    Fernández-Balsells MM; Murad MH; Lane M; Lampropulos JF; Albuquerque F; Mullan RJ; Agrwal N; Elamin MB; Gallegos-Orozco JF; Wang AT; Erwin PJ; Bhasin S; Montori VM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2560-75. PubMed ID: 20525906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone and cardiovascular disease.
    Schooling CM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):202-8. PubMed ID: 24722171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
    Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
    JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials.
    Casanova G; Bossardi Ramos R; Ziegelmann P; Spritzer PM
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1028-37. PubMed ID: 25514104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.
    Xu L; Freeman G; Cowling BJ; Schooling CM
    BMC Med; 2013 Apr; 11():108. PubMed ID: 23597181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.
    Calof OM; Singh AB; Lee ML; Kenny AM; Urban RJ; Tenover JL; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2005 Nov; 60(11):1451-7. PubMed ID: 16339333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews.
    Onasanya O; Iyer G; Lucas E; Lin D; Singh S; Alexander GC
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):943-956. PubMed ID: 27669646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].
    Rochoy M; Thomas R; Béné J; Deleplanque D; Vantyghem MC; Gautier S; Deplanque D;
    Prog Urol; 2018 May; 28(6):315-321. PubMed ID: 29650456
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.